Vivesto AB announced that the company's new permanent CEO Erik Kinnman will take up his position on January 23, 2023. Erik Kinnman has 27 years of experience from senior positions in Life Science, including AstraZeneca and Sobi, and has worked as a financial analyst at Danske Bank. He has been CEO for five years for Abliva, CEO of Sprint Bioscience for two years, and holds board member positions for Stayble and ISR. Erik has a background as a doctor specializing in neurology and pain management and is an associate professor at Karolinska Institutet.